Bailey Protzeller, | |
620 Hazel St, Arlington, WA 98223-8245 | |
(360) 403-8247 | |
Not Available |
Full Name | Bailey Protzeller |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 620 Hazel St, Arlington, Washington |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1518602150 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Bailey Protzeller, 25117 Sw Parkway Ave Ste D, Wilsonville, OR 97070-9697 Ph: (503) 570-3665 | Bailey Protzeller, 620 Hazel St, Arlington, WA 98223-8245 Ph: (360) 403-8247 |
News Archive
NIBIB-funded researchers at the University of Washington have pioneered an approach to image functional activity in the brains of individual fetuses, allowing a better look at how functional networks within the brain develop.
New research in mice shows that two commonly used gout medications, which target uric acid and adenosine triphosphate, may offer protection from alcohol-induced liver disease and inflammation.
A new wearable sensor that works in conjunction with artificial intelligence technology could help doctors remotely detect critical changes in heart failure patients days before a health crisis occurs and could prevent hospitalization, according to a study led by University of Utah Health and VA Salt Lake City Health Care System scientists.
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of treatments for the most challenging infectious diseases, today announced the nomination of a lead clinical candidate in its fourth proprietary program against hepatitis C virus (HCV) infection. The candidate, ACH-2928, is an NS5A inhibitor that in preclinical studies has demonstrated excellent potency against HCV RNA replication, as well as good pharmacokinetic and safety profiles.
Biocompatible gold nanoparticles designed to convert near-infrared light to heat have been shown to safely and effectively ablate low- to intermediate-grade tumors within the prostate, according to a study conducted at the Icahn School of Medicine and published in the journal Proceedings of the National Academy of Sciences.
› Verified 8 days ago
David Alexander Icanberry, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16710 Smokey Point Blvd Ste 402, Arlington, WA 98223 Phone: 360-363-4234 Fax: 360-363-4235 | |
Kaylee Ingraham, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 505 E 3rd St, Arlington, WA 98223 Phone: 253-549-6171 | |
Mr. Brenda Jean Leighton, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 19105 44th Ave Ne, Arlington, WA 98223 Phone: 425-422-9312 | |
Mr. Philip L Karlberg, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 315 N French Ave, Arlington, WA 98223 Phone: 360-618-6252 Fax: 360-618-6221 | |
Ms. Anna Catherine Sullivan, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 620 Hazel St, Arlington, WA 98223 Phone: 360-403-8247 | |
Mrs. Alison Claire Bartlett, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8213 Eaglefield Dr, Pioneer Elementary School, Arlington, WA 98223 Phone: 360-618-6230 |